Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 80 years old
- You have been diagnosed with prostate cancer (a specific type called adenocarcinoma, confirmed by a tissue sample)
- Your prostate cancer falls into the low, intermediate, or high-risk category based on standard medical guidelines
- Your cancer has not spread to nearby lymph nodes or other parts of the body
- You are generally well enough to carry out daily activities without significant difficulty (confirm with trial site)
- You have a good urinary flow rate or a low score on a standard urinary symptoms questionnaire (confirm with trial site)
- Your prostate gland is not too enlarged (smaller than 100 cc)
- You have had a special type of prostate MRI scan (called an mpMRI) available for review
- Your MRI shows fewer than 3 areas of concern in the prostate, and any areas included must meet certain scan scoring requirements (confirm with trial site)
- You are willing and able to give written consent to take part in the treatment and research
Who may not be able to join:
- Your blood platelet count is too low (below 75,000), which can affect blood clotting
- You have a narrowing of the urethra (the tube that carries urine out of the body)
- You have previously had radiation therapy to the pelvic area
- You have inflammatory bowel disease or other serious ongoing health conditions
- You have previously had surgery to remove your prostate
- You have a hip replacement (prosthesis) on either side
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Barbara Alicja Jereczek, European Institute of Oncology
Phone: +39 0257489037
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Participants with Acute GU and GI toxicities (RTOG); Number of Participants with Late GU and GI toxicities (RTOG); Evaluation of patient-reported toxicity; Evaluation of patient-reported quality of life
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.